LIPENTRA

Serial Number 77930879
606

Registration Progress

Application Filed
Feb 8, 2010
Under Examination
Aug 17, 2010
Approved for Publication
Jun 22, 2010
Published for Opposition
Jun 22, 2010
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: LIPENTRA
Previous Owner: Abbott Laboratories
Classes: 005

Trademark Image

LIPENTRA

Basic Information

Serial Number
77930879
Filing Date
February 8, 2010
Published for Opposition
June 22, 2010
Abandonment Date
March 21, 2011
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 21, 2011
Classes
005

Rights Holder

Abbott Laboratories

03
Address
100 Abbott Park Road
Abbott Park, IL 60064

Ownership History

Abbott Laboratories

Original Applicant
03
Abbott Park, IL

Abbott Laboratories

Owner at Publication
03
Abbott Park, IL

Legal Representation

Attorney
Mary L. Winburn

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Mar 21, 2011 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 21, 2011 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 17, 2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 22, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 22, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 19, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 19, 2010 ALIE A ASSIGNED TO LIE Loading...
May 10, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 10, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 17, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 11, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of artheriosclerotic diseases, autoimmune diseases, cancer, cardiovascular diseases, central nervous system diseases, diabetes and other metabolic disorders, inflammation and inflammatory diseases, respiratory and infectious diseases, peripheral and central vascular diseases, seizure disorders, shock and central nervous system trauma, stroke, and viral diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005